Back to top

IDYA Maintains Outperform Rating by RBC Capital -- Price Target Lowered to $48

IDYA Maintains Outperform Rating by RBC Capital -- Price Target Lowered to $48

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

IDEAYA Biosciences, Inc. (IDYA)